Dramatic results seen in phase III front-line multiple myeloma trials of bortezomib-based therapy

被引：0
|
作者：
不详
机构：
来源：
ONCOLOGY-NEW YORK | 2008年 / 22卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：80 / 81
页数：2
相关论文
共 50 条
  • [31] Early mortality and treatment discontinuation in multiple myeloma patients treated in front-line with bortezomib, lenalidomide and dexamethasone (VRD)
    Oriol, Albert
    Canelo-Vilaseca, Marta
    Sanchez, Carla
    Abril, Laura
    Escoda, Lourdes
    Ibarra, Gladys
    Abella, Eugenia
    Motllo, Cristina
    Gonzalez-Montes, Yolanda
    Granada, Isabel
    Cabezudo, Elena
    Senin, Alicia
    Ben, Randa
    Jurado, Rebeca
    de Jaureguizar, Alejandro
    Ribera, Josep-Maria
    Sarra, Josep
    Sancho, Juan-Manuel
    Sureda, Anna
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S146 - S147
  • [32] Bortezomib-based therapy for relapsed/refractory multiple myeloma in real-world medical practice
    Terpos, Evangelos
    Katodritou, Eirini
    de la Rubia, Javier
    Hungria, Vania
    Hulin, Cyrille
    Roussou, Maria
    Delforge, Michel
    Bries, Greet
    Stoppa, Anne-Marie
    Aagesen, Jesper
    Sargin, Deniz
    Belch, Andrew
    Ahlberg, Lucia
    Diels, Joris
    Olie, Robert A.
    Robinson, Don, Jr.
    Spencer, Mike
    Potamianou, Anna
    van de Velde, Helgi
    Dimopoulos, Meletios A.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2018, 101 (04) : 556 - 565
  • [33] Bortezomib, doxorubicin and dexamethasone (PAD) front-line treatment of multiple myeloma: updated results after long-term follow-up
    Popat, Rakesh
    Oakervee, Heather E.
    Hallam, Simon
    Curry, Nicola
    Odeh, Liz
    Foot, Nicola
    Esseltine, Dixie-Lee
    Drake, Mary
    Morris, Curly
    Cavenagh, Jamie D.
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 141 (04) : 512 - 516
  • [34] Peripheral neuropathy induced by subcutaneous bortezomib-based induction therapy for newly diagnosed multiple myeloma
    Brioli, Annamaria
    Zannetti, Beatrice Anna
    Zamagni, Elena
    Tacchetti, Paola
    Pantani, Lucia
    Mancuso, Katia
    Pezzi, Annalisa
    Rocchi, Serena
    Cavo, Michele
    HAEMATOLOGICA, 2014, 99 (11)
  • [35] EFFICACY OF BORTEZOMIB-BASED THERAPY IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: Results FROM AN ELECTRONIC BORTEZOMIB OBSERVATIONAL STUDY (EVOBS) FOR PATIENT ENROLLED IN RUSSIAN FEDERATION
    Abdulkadyrov, K.
    Schmidt, A.
    Voloshin, S.
    Shuvaev, V.
    Kuvshinov, A.
    HAEMATOLOGICA, 2012, 97 : 598 - 599
  • [36] Secondary Analysis of the MM21 Trial: Response Adaptive Salvage Treatment with Daratumumab-LenalidomideDexamethasone (DRd) for Newly Diagnosed Transplant Eligible Multiple Myeloma Patients Failing Front-Line Bortezomib-Based Induction Therapy
    Lim, Sueh-li
    Reynolds, John
    Quach, Hang
    Hutchinson, Anna
    Kerridge, Ian H.
    Estell, Jane
    Wallington-Gates, Craig
    Kalff, Anna
    Yuen, Flora
    Spencer, Andrew
    BLOOD, 2022, 140 : 10174 - 10176
  • [37] Preliminary Analysis of the MM21 Trial: Response Adaptive Salvage Treatment with Daratumumab-LenalidomideDexamethasone (DRd) for Newly Diagnosed Transplant Eligible Multiple Myeloma Patients Failing Front-Line Bortezomib-Based Induction Therapy
    Lim, Sueh-li
    Reynolds, John
    Quach, Hang
    Hutchinson, Anna
    Kerridge, Ian H.
    Estell, Jane
    Janowski, Wojt
    Wallington-Beddoe, Craig Thomas
    Kalff, Anna
    Yuen, Flora
    Spencer, Andrew
    BLOOD, 2021, 138
  • [38] Response adaptive salvage treatment with daratumumab-lenalidomide-dexamethasone for newly diagnosed transplant-eligible multiple myeloma patients failing front-line bortezomib-based induction therapy-ALLG MM21
    Lim, S.
    Reynolds, J.
    Quach, H.
    Hutchinson, A.
    Kerridge, I.
    Janowski, W.
    Bergin, K.
    Spencer, A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 205 (03) : 900 - 914
  • [39] EFFICACY AND SAFETY OF BORTEZOMIB-BASED RETREATMENT IN MULTIPLE MYELOMA (MM) PATIENTS RELAPSING AFTER BORTEZOMIB-CONTAINING FIRST-LINE THERAPY: A RETROSPECTIVE STUDY
    Oriol, A.
    Giraldo, P.
    Kotsianidis, I.
    Couturier, C.
    Angermund, R.
    Broer, E.
    Corso, A.
    HAEMATOLOGICA, 2012, 97 : 609 - 610
  • [40] BORTEZOMIB-BASED REGIMENS AS INDUCTION AND MAINTENANCE TREATMENT IN MULTIPLE MYELOMA (MM) PATIENTS NOT ELIGIBLE FOR AGGRESSIVE THERAPY
    Mazzone, C.
    Gentile, M.
    Vigna, E.
    Lucia, E.
    Lorio, C.
    Morelli, R.
    Bisconte, M. G.
    Gentile, C.
    Morabito, F.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 544 - 544
12345